1-3 of 3
Kyra Michalova, Prof., PhD.
Close
Sort by
Journal Articles

The Significance Of Fli1 and p53 For The Effective Megakaryopoiesis In 5q- Syndrome and The Effect Of Lenalidomide Treatment

Radana Neuwirtova, MD, PhD, Jan Stritesky, MD, PhD, Ota Fuchs, PhD, Martin Vostry, Arnost Kostecka, Monika Belickova, PhD, Magdalena Siskova, MD, PhD, Kyra Michalova, prof., PhD, Jaroslav Cermak, Ass. Prof., PhD, Anna T Jonasova, MD
Journal: Blood
Blood (2013) 122 (21): 5208.
https://doi.org/10.1182/blood.V122.21.5208.5208
Published: 2013
Journal Articles

A reclassification of Myelodysplastic Syndrome (MDS) patients of RAEB-1 subgroup according to IPSS-R improves discrimination of high risk patients and better predicts overall Survival. A retrospective analysis of 49 Patients

Jaroslav Cermak, MD, PhD, Dana Mikulenková, MD, Jana Brezinova, MD, PhD, Kyra Michalova, prof., PhD
Journal: Blood
Blood (2012) 120 (21): 4957.
https://doi.org/10.1182/blood.V120.21.4957.4957
Published: 2012
Journal Articles

Frequency and Prognostic Impact of Complex Chromosomal Aberrations in Patients with Primary Myelodysplastic Syndromes and Del(5q).

Zuzana Zemanova, Ass.Prof., Ph.D., Kyra Michalova, Prof., PhD., Jana Brezinova, Libuse Lizcova, Silvia Izakova, Dagmar Bystricka, PhD, Iveta Sarova, Adela Berkova, MD, Magda Siskova, MD, Radana Neuwirtova, MD, PhD, Olga Cerna, MD, Jaroslav Cermak, M.D., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 1623.
https://doi.org/10.1182/blood.V114.22.1623.1623
Published: 2009